Clinical Trials in London, Surrey
4 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
MetastasisCastration-Resistant Prostatic Cancer
Merck Sharp & Dohme LLC360 enrolled67 locationsNCT06863272
Recruiting
Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Merck Sharp & Dohme LLC1,123 enrolled232 locationsNCT06952504
Recruiting
Not Applicable
Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits
Adenocarcinoma of the Rectum
Imperial College London200 enrolled1 locationNCT03303547
Recruiting
Phase 2
Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression
Metastatic Breast CancerAdvanced Breast CancerER+ Breast Cancer
Royal Marsden NHS Foundation Trust324 enrolled18 locationsNCT04920708